Eyebright Medical Technology Co., Ltd. logo

Eyebright Medical Technology Co., Ltd. (688050)

Market Open
10 Aug, 06:57
SSE SSE
¥
41. 85
+0.79
+1.924%
¥
18.82B Market Cap
- P/E Ratio
1.96% Div Yield
4.76M Volume
- Eps
¥ 41.06
Previous Close
Add Transaction
Day Range
40.72 43.05
Year Range
35.23 83.83
Want to track 688050 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

688050 trading today higher at ¥41.85, an increase of 1.924% from yesterday's close, completing a monthly increase of 14.7833% or ¥5.39. Over the past 12 months, 688050 stock lost -31.0998%.
688050 pays dividends to its shareholders, with the most recent payment made on Jun 22, 2026. The next estimated payment will be in In 10 months on Jun 22, 2027 for a total of ¥0.32.
The last earnings report, released on Apr 16, 2026, missed the consensus estimates by -0.49%. On average, the company has fell short of earnings expectations by -0.5033%, based on the last three reports.
Eyebright Medical Technology Co., Ltd. has completed 1 stock splits, with the recent split occurring on Jun 05, 2024.
The company's stock is traded on one exchange.

688050 Chart

People also search for

Will Semiconductor Co., Ltd.
¥ 92.7
+3.9937%
Beijing Kingsoft Office Software Inc.
¥ 265.36
+1.051%
Advanced Micro-Fabrication Equipment Inc.
¥ 375.14
-3.8078%
Longi Green Energy Technology Co., Ltd.
¥ 12.96
+0.1546%
Shenzhen Transsion Holdings Co. Ltd.
¥ 57.35
-1.3079%

Eyebright Medical Technology Co., Ltd. (688050) FAQ

What is the stock price today?

The current price is ¥41.85.

On which exchange is it traded?

Eyebright Medical Technology Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 688050.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.96%.

What is its market cap?

As of today, the market cap is 18.82B.

Has Eyebright Medical Technology Co., Ltd. ever had a stock split?

Eyebright Medical Technology Co., Ltd. had 1 splits and the recent split was on Jun 05, 2024.

Eyebright Medical Technology Co., Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Jiangbing Xie CEO
SSE Exchange
CNE1000041J5 ISIN
CN Country
2,074 Employees
22 Jun 2026 Last Dividend
5 Jun 2024 Last Split
- IPO Date

Overview

Eyebright Medical Technology (Beijing) Co., Ltd. is a prominent company based in Beijing, China, specializing in the development of an extensive range of ophthalmic medical products. Since its establishment in 2010, the company has dedicated itself to addressing the needs of patients with ophthalmic diseases and vision problems. Eyebright Medical Technology is renowned for its commitment to innovation, quality, and patient care in the field of ophthalmology. With a focus on creating solutions that improve patients' quality of life, the company caters to a broad spectrum of ophthalmic conditions, including cataracts, glaucoma, refractive errors, and more.

Products and Services

Eyebright Medical Technology offers a comprehensive portfolio of products and services designed to meet the diverse needs of ophthalmic care professionals and their patients:

  • Surgical Implants and Instruments: The company provides a wide array of surgical implants and instruments specifically designed for various ophthalmic surgeries. These products are crafted to aid in the precise treatment of conditions such as cataracts and glaucoma, ensuring high levels of efficacy and safety during surgical procedures.
  • Equipment: Eyebright Medical Technology offers cutting-edge equipment for the diagnosis, treatment, and management of ophthalmic diseases. This includes advanced imaging systems, laser treatment devices, and other diagnostic tools that enhance the capability of ophthalmologists to deliver comprehensive eye care.
  • Optometric Lenses: To address refractive errors and improve vision clarity, the company produces a variety of optometric lenses. These include prescription glasses and contact lenses tailor-made to meet individual visual requirements, helping patients achieve better sight functionality in their daily lives.
  • Eye Drops: The company also develops and markets a range of eye drops for the treatment and maintenance of ocular health. These products are formulated to provide relief from dry eye syndrome, reduce inflammation, and prevent infection, contributing to overall eye comfort and well-being.

Contact Information

Address: Changping Science & Technology Park, Beijing, China, 102200
Phone: 86 10 6074 5730